Table 2.
Control (above) and patient (below) demographics, maximal lymphatic vessel cross-sectional areas, and radiological scores. All patient values are shown, along with those for only sub-clinical patients (Stage 0) and symptomatic patients (Stages 1 and 2). Values shown are mean ± one standard deviation.
| N | Age [range] (years) |
Handedness (% right) |
Nodes removed (number) |
Left area (mm2) |
Right area (mm2) |
Left area (mm2) |
Right area (mm2) |
Left | Right | |
|---|---|---|---|---|---|---|---|---|---|---|
| Torso | Torso | Arm | Arm | Score | Score | |||||
| Controls | 11 | 50 [33–68] | 100 | 0.0±0.0 | 8.7±2.1 | 8.7±2.8 | 8.8±4.2 | 8.4±1.6 | 1.9±0.8 | 1.9±0.8 |
| N |
Age [range] (yrs) |
Affected side (% right) |
Nodes removed (number) |
Affected vessel area (mm2) |
Contralateral vessel area (mm2) |
Affected vessel area (mm2) |
Contralateral vessel area (mm2) |
Affected | Contralateral | |
| Torso | Torso | Arm | Arm | Score | Score | |||||
| All Patients | 25 | 62 [44–80] | 26.9 | 8.2±7.4 | 17.2±15.6 | 9.1±4.6 | 12.9±6.3 | 9.4±3.9 | 2.1±1.3 | 2.2±1.3 |
|
Patients (Stage 0) |
14 | 61 [44–74] | 14.3 | 4.1±2.8 | 12.8±6.5 | 9.0±5.1 | 12.1±5.8 | 8.8±4.3 | 1.5±0.8 | 2.3±1.3 |
|
Patients (Stages 1–2) |
11 | 63 [46–80] | 41.2 | 13.5±8.2 | 22.9±21.8 | 9.3±4.1 | 13.9±7.0 | 10.3±3.4 | 2.7±1.5 | 2.0±1.4 |